HealthDay News — US veterans infected with COVID-19 have an increased risk for mortality during days 0 to 90 and 91 to 180, but risk is reduced thereafter through 2 years, according to a study published online Aug. 21 in JAMA Internal Medicine.
Theodore J. Iwashyna, M.D., Ph.D., from Ann Arbor Veterans Affairs in Michigan, and colleagues conducted a retrospective cohort study using prospectively collected health record data from Veterans Affairs hospitals across the United States for veterans who had COVID-19 between March 2020 and April 2021. Each individual was matched with up to 5 comparators who had not been infected with COVID-19. Data were included for 208,061 veterans with COVID-19 infection and 1,037,423 matched uninfected comparators.
Researchers found that during the 2-year period after initial infection, the unadjusted mortality rate was 8.7% for veterans with COVID-19 compared with 4.1% among uninfected comparators (adjusted hazard ratio, 2.01, with censoring if the comparator later developed COVID-19). There was variation in the risk for excess death, with the highest risk during days 0 to 90 after infection and elevated risk during days 91 to 180 (adjusted hazard ratios, 6.36 and 1.18, respectively). Mortality was reduced on days 181 to 365 and 366 to 730 among those who survived COVID-19 (adjusted hazard ratios, 0.92 and 0.89, respectively). Across sensitivity analyses, the patterns were consistent.
“This finding has individual level and health system planning implications and should be reassuring to persons who have survived COVID-19 for at least 180 days,” the authors write.
Two authors disclosed ties to the biopharmaceutical industry.